Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Chronic Renal Failure Patients on Hemodialysis
NCT02331680Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolvaptan in chronic kidney disease (CKD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02331680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331680.